BioCardiAa (BCDA) PT Lowered to $19 at Brookline Capital Markets, Following Earnings
Tweet
Share
E-mailGet Alerts BCDA Hot Sheet
Price: $0.93 --0%
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 8
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 8
Join SI Premium – FREE
Brookline Capital Markets analyst Kumaraguru Raja lowered the price target on BioCardiAa (NASDAQ: BCDA) to $19.00 (from $22.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bullish (BLSH) PT Raised to $30 at Compass Point
- FGI Industries (FGI) PT Raised to $13 at Benchmark as Full Year Guide Reiterated
- Nu Holdings (Nubank) (NU) PT Raised to $19 at Needham
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
